News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
The European Medicines Agency (EMA) has recommended authorization of the Pfizer/ BioNTech COVID-19 vaccine: paving the way for the first marketing authorization of a COVID-19 vaccine in Europe.
A US advisory panel has recommended the next two US priority population groups to receive the COVID-19 vaccine should be those 75 and older and essential workers.
It is known and expected that viruses constantly change through mutation leading to the emergence of new variants, but preliminary analysis in the UK suggests the new SARS-CoV-2 variant is significantly more transmissible than previous ones.